A Study of INCB059872 and INCB057643 in Relapsed or Refractory Ewing Sarcoma
Conditions:   Relapsed Ewing Sarcoma;   Refractory Ewing Sarcoma Interventions:   Drug: INCB059872;   Drug: INCB057643 Sponsor:   Incyte Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 2, 2018 Category: Research Source Type: clinical trials